Skip to main content

News

Uppsala BIO contributes to a successful year for Testa Center

Uppsala BIO contributes to a successful year for Testa Center

News   •   Oct 03, 2019 12:06 UTC

Fifteen projects from Scandinavia have so far benefited from the technology and know-how available at Testa Center. Uppsala BIO has a crucial role in the development and establishment of Testa Center, resulting in the increased overall value of the Testa Center projects.

Science Fiction becomes reality – CAR T cells and the transformation of medicine

Science Fiction becomes reality – CAR T cells and the transformation of medicine

News   •   Jun 24, 2019 11:08 UTC

Efter Jobbet Harvesting human cells are not easy. The scientists started harvesting T cells from people several years ago, then genetically altering them, to add chimeric antigen receptor (CAR) that specifically recognizes cancer cells and then infuse the resulting CAR-T cells into patients to attack their tumors.

Successful spring edition of Efter Jobbet

Successful spring edition of Efter Jobbet

News   •   Apr 17, 2019 11:59 UTC

​ We are glad to have a very successful start of the spring series of Efter Jobbet, an event organized by Uppsala BIO., where we tackle hot topics of the Life Science industry in a casual atmosphere

From hospital walls to where the patient is

From hospital walls to where the patient is

News   •   Apr 15, 2019 12:11 UTC

Redefining the future of Healthcare through the Vision e-Health 2025 is an inevitable process for the Life Science industry, according to Patrik Sundström, Head of e Health at The Swedish Association of Local Authorities and Regions SKL.

Testa Center: Scaling up the value

Testa Center: Scaling up the value

News   •   Apr 09, 2019 09:11 UTC

Spinach, antibodies, virtual reality. Lots of exciting projects in the state-of-the-art facility, Testa Center, a major initiative between the Swedish Government and GE. Scaling up to the large volume and gaining a new level of knowledge bring enthusiasm and positivity among the team and the actors at the authentic industrial test-bed, Testa Center.

Klövern chooses Uppsala BIO as partner for continued development in rapidly-growing Uppsala

Klövern chooses Uppsala BIO as partner for continued development in rapidly-growing Uppsala

News   •   Jan 17, 2019 15:09 UTC

Uppsala BIO and the real estate company Klövern have signed a three-year collaboration agreement for the further development of Uppsala Business Park located in Fyrislund, the city’s southernmost industry district. The ambition is to create a new business district for innovation and growth as part of a world-leading life science region.

National coordination and clearer rules for smoother introduction of digital tools into Swedish healthcare

News   •   Nov 08, 2018 09:23 UTC

Uppsala BIO was part of initiating a pilot study in 2016, which in 2017 led to Ordnat införande av digitala produkter och tjänster (ordered introduction of digital products and services), a collaborative effort led by SKL (Sveriges Kommuner och Landsting/ Swedish Association of Local Authorities and Regions) together with Region Norrbotten, Stockholm Science City and Uppsala BIO.

Testa Center inaugurated!

Testa Center inaugurated!

News   •   Aug 23, 2018 11:26 UTC

On 21 August, Testa Center – Sweden’s national test environment for verifying biological and technological tools used in manufacturing biologics or biopharmaceuticals – was officially inaugurated. And the first projects are ready to move in and get going!

NeoProteomics AB moves to Uppsala

News   •   Aug 23, 2018 11:14 UTC

This August, we see a new and exciting addition to Uppsala`s life science business sector. Based on research by Professor Gert Auer at Karolinska Institute, NeoProteomics AB started the development of biomarkers for sensitive and risk-free cancer diagnosis by analyzing platelets role in cancer.

Cavidi gears up for market growth thanks to new investment partner

Cavidi gears up for market growth thanks to new investment partner

News   •   Aug 21, 2018 14:12 UTC

Uppsala-based life science company Cavidi is an expert in HIV monitoring. Its first commercial product was a manual test for HIV monitoring in resource-limited settings, ExaVir Load. This product was an important step in taking care closer to the HIV-infected population in the parts of the world that are most affected.